Company intelligence / Profile preview

Medzown

Jupiter, Florida, United Statesmedzown.com ↗

Ownership: Private
Development stage: Commercial

Overview

Medzown provides precision medicine management services at scale. They leverage advanced analytics and deep expertise to connect patients with cancer or rare/complex diseases to cutting-edge treatments—including immunotherapies, targeted therapies, cell/gene therapies—and facilitate access to clinical trials. Their approach improves patient outcomes while controlling specialty pharmacy costs for payers and providers. The company builds on the legacy of N-of-One’s molecular oncology decision support platform.

Therapeutic areas: OncologyRare Diseases
Modalities: ImmunotherapyTargeted therapyCell therapyGene therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaborates broadly with payers, providers, pharma companies for trial enrollment and care navigation.

Beyond the preview

Go deeper on Medzown.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medzown.

Explore the full profile